Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism - Comparison with high density lipoprotein-mediated reverse cholesterol transport

被引:205
|
作者
Babiker, A
Andersson, O
Lund, E
Xiu, RJ
Deeb, S
Reshef, A
Leitersdorf, E
Diczfalusy, U
Bjorkhem, I
机构
[1] KAROLINSKA INST,DEPT MED LAB SCI & TECHNOL,SE-14186 HUDDINGE,SWEDEN
[2] KAROLINSKA INST,CLIN RES CTR,SE-14186 HUDDINGE,SWEDEN
[3] KAROLINSKA INST,DEPT LUNG MED,SE-14186 HUDDINGE,SWEDEN
[4] HADASSAH UNIV HOSP,DIV MED,CTR RES PREVENT & TREATMENT ATHEROSCLEROSIS,IL-91120 JERUSALEM,ISRAEL
关键词
D O I
10.1074/jbc.272.42.26253
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cultured macrophages and endothelial cells have been reported to secrete 27-oxygenated metabolites of cholesterol, This mechanism was compared with the classical high density lipoprotein (HDL)-dependent reverse cholesterol transport, Under standard conditions, macrophage preparations had considerably higher capacity to secrete 27-hydroxycholesterol and 3 beta-hydroxy-5-cholestenoic acid than had endothelial cells and fibroblasts, Western blotting showed that lung macrophages contained the most sterol 27-hydroxylase protein of the cells tested, The relative amounts of 3 beta-hydroxy-5-cholestenoic acid produced by the macrophages were also highest, Macrophages derived from monocytes of patients with sterol 27-hydroxylase deficiency did not secrete 27-oxygenated products, demonstrating that sterol 27-hydroxylase is the critical enzyme for the conversion of cholesterol into the 27-oxygenated steroids, That sterol 27-hydroxylase is responsible not only for 27-hydroxylation of cholesterol but also for time further oxidation of this steroid into 3 beta-hydroxy-5-cholestenoic acid was shown with use of tritium-labeled 27-hydroxy-cholesterol and an inhibitor of sterol 27-hydroxylase. Secretion of 27-oxygenated products by the cultured macrophages as well as the ratio between the alcohol and the acid appeared to be dependent upon total 27-hydroxylase activity, the availability of substrate cholesterol, and the presence of an acceptor for 27-hydroxy-cholesterol in the medium, With albumin as extracellular acceptor, the major secreted product was 3 beta-hydroxy-5-cholestenoic acid. Under such conditions, secretion of labeled 27-oxygenated products was higher than that of labeled cholesterol from lung alveolar macrophages preloaded with [4-C-14]cholesterol. With HDL as acceptor, 27-hydroxycholesterol was the major secreted product, and the total secretion of labeled 27-oxygenated products was only about 10% of that of labeled cholesterol, Thus, 27-hydroxycholesterol and cholesterol may compete for HDL-mediated efflux from the cells. The results support the contention that the sterol 27-hydroxylase-mediated elimination of cholesterol is more important in macrophages than in endothelial cell. This mechanism may be an alternative and/or a complement to the classical HDL-mediated reverse cholesterol transport in macrophages, in particular when the concentration of HDL is low.
引用
收藏
页码:26253 / 26261
页数:9
相关论文
共 50 条
  • [41] Fibrates suppress bile acid synthesis via PPARα-mediated down-regulation of cholesterol 7α-hydroxylase and sterol 27-hydroxylase gene expression
    Post, SM
    Staels, B
    de Fabiani, E
    Chiang, JYL
    Princen, HMG
    Crestani, M
    ATHEROSCLEROSIS, 1999, 144 : 23 - 23
  • [42] BARIATRIC SURGERY ENHANCES REVERSE CHOLESTEROL TRANSPORT AND HIGH DENSITY LIPOPROTEIN FUNCTIONALITY
    Ho, J. H.
    Adam, S.
    Siahmansur, T.
    Liu, Y.
    Azmi, S.
    Aghamohammadzadeh, R.
    Siddals, K.
    Malik, R. A.
    Syed, A. A.
    Ammori, B. J.
    Durrington, P. N.
    Donn, R.
    Soran, H.
    ATHEROSCLEROSIS, 2018, 275 : E35 - E36
  • [43] Reverse cholesterol transport: High-density lipoprotein’s magnificent mile
    Peter P. Toth
    Current Atherosclerosis Reports, 2003, 5 (5) : 386 - 393
  • [44] JCL roundtable: High-density lipoprotein function and reverse cholesterol transport
    Cuchel, Marina
    Rohatgi, Anand
    Sacks, Frank M.
    Guyton, John R.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (05) : 1086 - 1094
  • [45] Genetic dissection of high-density lipoprotein metabolism and reverse cholesterol transport
    Assmann, G
    von Eckardstein, A
    Walter, M
    Cullen, P
    ATHEROSCLEROSIS XI, 1998, 1155 : 19 - 28
  • [46] Molecular interaction between caveolin-1 and ABCA1 on high-density lipoprotein-mediated cholesterol efflux in aortic endothelial cells
    Lin, Yu-Chun
    Ma, Chang
    Hsu, Wei-Ching
    Lo, Hsiao-Fan
    Yang, Vivian C.
    CARDIOVASCULAR RESEARCH, 2007, 75 (03) : 575 - 583
  • [47] Molecular mechanism of reverse cholesterol transport:: Reaction of pre-β-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase
    Nakamura, Y
    Kotite, L
    Gan, Y
    Spencer, TA
    Fielding, CJ
    Fielding, PE
    BIOCHEMISTRY, 2004, 43 (46) : 14811 - 14820
  • [48] HIGH-DENSITY-LIPOPROTEIN RECEPTOR-MEDIATED TRANSPORT OF EXCESS CHOLESTEROL FROM CELLS
    ORAM, JF
    SLOTTE, JP
    AVIRAM, M
    DUELL, PB
    GRAHAM, DL
    BIERMAN, EL
    HIGH DENSITY LIPOPROTEINS AND ATHEROSCLEROSIS II, 1989, 826 : 225 - 232
  • [49] MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High-Density Lipoprotein, and Low-Density Lipoprotein Receptor-Mediated Reverse Cholesterol Transport
    George, Richard T.
    Abuhatzira, Liron
    Stoughton, Susan M.
    Karathanasis, Sotirios K.
    She, Dewei
    Jin, ChaoYu
    Buss, Nicholas A. P. S.
    Bakker-Arkema, Rebecca
    Ongstad, Emily L.
    Koren, Michael
    Hirshberg, Boaz
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (13):
  • [50] Reduction of high density lipoprotein cholesterol after successfull dietary intervention is not accompanied by a change in reverse cholesterol transport
    Poledne, Rudolf
    CIRCULATION, 2007, 116 (16) : 15 - 15